BIOKIN (02615.HK) Stock Community - Hot Topic Discussions

Quote List Quote List

Event Tracking

Dec7

Belayidiantianhen Publishes Clinical Study Results of T-Bren (BL-M07D1)

10:48

Nov30

BMS Pays $250 Million Milestone Payment to Bailing Tianheng's Subsidiary

08:59

Nov23

Belayi Tianheng's EGFR×HER3 Dual Antibody ADC Drug Marketing Application Accepted for Review

07:45

Nov18

Bailitiantian's Iza-bren Reaches Dual Primary Endpoints in Phase III Clinical Trials for Esophageal Cancer

00:26

Oct26

BIOKIN released FY2025 Q3 earnings on October 26, 2025 (BJT) with actual revenue of HKD 2.071 B and EPS of HKD 1.6838

15:00

BIOKIN released FY2025 9 Months Earnings on October 26, 2025 (BJT) with actual revenue of HKD 2.257 B and EPS of HKD -1.3381

15:00

Schedules & Filings

Schedules

Filings

Nov17

IPO(CST)

Listing Price HKD 347.5 ~ 389

Oct26

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 2.071 B, Net Income 681.52 M, EPS 1.6838

Aug19

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 113.56 M, Net Income -641.95 M, EPS -1.5976

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change